These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35955107)

  • 41. Experiences, Attitudes, and Needs of Users of a Pregnancy and Parenting App (Baby Buddy) During the COVID-19 Pandemic: Mixed Methods Study.
    Rhodes A; Kheireddine S; Smith AD
    JMIR Mhealth Uhealth; 2020 Dec; 8(12):e23157. PubMed ID: 33264100
    [TBL] [Abstract][Full Text] [Related]  

  • 42. How did the first COVID-19 lockdown affect persons with concurrent mental health and substance use disorders in Norway? A qualitative study.
    Leonhardt M; Brodahl M; Cogan N; Lien L
    BMC Psychiatry; 2022 Mar; 22(1):179. PubMed ID: 35287637
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Opioid use disorder treatment disruptions during the early COVID-19 pandemic and other emergent disasters: a scoping review addressing dual public health emergencies.
    Henderson R; McInnes A; Mackey L; Bruised Head M; Crowshoe L; Hann J; Hayward J; Holroyd BR; Lang E; Larson B; Leonard AJ; Persaud S; Raghavji K; Sarin C; Virani H; Wadsworth IW; Whitman S; McLane P
    BMC Public Health; 2021 Jul; 21(1):1471. PubMed ID: 34320954
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Signal of increased opioid overdose during COVID-19 from emergency medical services data.
    Slavova S; Rock P; Bush HM; Quesinberry D; Walsh SL
    Drug Alcohol Depend; 2020 Sep; 214():108176. PubMed ID: 32717504
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increases in Naloxone Administrations by Emergency Medical Services Providers During the COVID-19 Pandemic: Retrospective Time Series Study.
    Khoury D; Preiss A; Geiger P; Anwar M; Conway KP
    JMIR Public Health Surveill; 2021 May; 7(5):e29298. PubMed ID: 33999828
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of the COVID-19 pandemic on illicit drug supply, drug-related behaviour of people who use drugs and provision of drug related services in Georgia: results of a mixed methods prospective cohort study.
    Otiashvili D; Mgebrishvili T; Beselia A; Vardanashvili I; Dumchev K; Kiriazova T; Kirtadze I
    Harm Reduct J; 2022 Mar; 19(1):25. PubMed ID: 35264181
    [TBL] [Abstract][Full Text] [Related]  

  • 47. "I'm putting a Band-Aid on a bullet hole the only way I know how:" a qualitative study of barriers and facilitators to opioid misuse and recovery in Nevada.
    Swigart T; Lee L
    Subst Abuse Treat Prev Policy; 2022 Nov; 17(1):76. PubMed ID: 36424601
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A clash of epidemics: Impact of the COVID-19 pandemic response on opioid overdose.
    Linas BP; Savinkina A; Barbosa C; Mueller PP; Cerdá M; Keyes K; Chhatwal J
    J Subst Abuse Treat; 2021 Jan; 120():108158. PubMed ID: 33298298
    [TBL] [Abstract][Full Text] [Related]  

  • 49. "Even if I'm undetectable, I just feel like I would die": a qualitative study to understand the psychological and socioeconomic impacts of the COVID-19 pandemic on women living with HIV (WLWH) in Chicago, IL.
    Devlin SA; Johnson AK; McNulty MC; Joseph OL; Hall A; Ridgway JP
    BMC Womens Health; 2022 Jun; 22(1):218. PubMed ID: 35689277
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An examination of telehealth policy impacts on initial rural opioid use disorder treatment patterns during the COVID-19 pandemic.
    Hughes PM; Verrastro G; Fusco CW; Wilson CG; Ostrach B
    J Rural Health; 2021 Jun; 37(3):467-472. PubMed ID: 33720447
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Access to Healthcare and Harm Reduction Services During the COVID-19 Pandemic for People Who Use Drugs.
    Stowe MJ; Calvey T; Scheibein F; Arya S; Saad NA; Shirasaka T; Dannatt L; Ghosh A; Yee A; Ratta-Apha W; Vadivel R; Siste K; Shah B; Ramalho R; Narasimha VL; Delic M; Peyron E; Onoria JLG; Pant SB; Boujraf S; Grandinetti P; Morgan N
    J Addict Med; 2020 Dec; 14(6):e287-e289. PubMed ID: 33009167
    [TBL] [Abstract][Full Text] [Related]  

  • 52. COVID-19-Related Changes to Drug-Selling Networks and Their Effects on People Who Use Illicit Opioids.
    Frank D; Krawczyk N; Arshonsky J; Bragg MA; Friedman SR; Bunting AM
    J Stud Alcohol Drugs; 2023 Mar; 84(2):222-229. PubMed ID: 36971722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emergency Department Visits for Nonfatal Opioid Overdose During the COVID-19 Pandemic Across Six US Health Care Systems.
    Soares WE; Melnick ER; Nath B; D'Onofrio G; Paek H; Skains RM; Walter LA; Casey MF; Napoli A; Hoppe JA; Jeffery MM
    Ann Emerg Med; 2022 Feb; 79(2):158-167. PubMed ID: 34119326
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A qualitative study of service engagement and unmet needs among unstably housed people who inject drugs in Massachusetts.
    Hassan R; Roland KB; Hernandez B; Goldman L; Evans KN; Gaul Z; Agnew-Brune C; Buchacz K; Fukuda HD
    J Subst Abuse Treat; 2022 Jul; 138():108722. PubMed ID: 35067399
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors affecting the mental health of pregnant women using UK maternity services during the COVID-19 pandemic: a qualitative interview study.
    McKinlay AR; Fancourt D; Burton A
    BMC Pregnancy Childbirth; 2022 Apr; 22(1):313. PubMed ID: 35413807
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review.
    Alexander K; Pogorzelska-Maziarz M; Gerolamo A; Hassen N; Kelly EL; Rising KL
    Subst Abuse Treat Prev Policy; 2021 Aug; 16(1):60. PubMed ID: 34372900
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exploring the impact of COVID-19 on substance use patterns and service access of street involved individuals in Kingston, Ontario: a qualitative study.
    McCann V; Allen R; Purkey E
    BMC Public Health; 2022 Mar; 22(1):571. PubMed ID: 35317773
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Investigating the relationship of COVID-19 related stress and media consumption with schizotypy, depression, and anxiety in cross-sectional surveys repeated throughout the pandemic in Germany and the UK.
    Daimer S; Mihatsch LL; Neufeld SAS; Murray GK; Knolle F
    Elife; 2022 Jul; 11():. PubMed ID: 35781372
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial.
    Hser YI; Ober AJ; Dopp AR; Lin C; Osterhage KP; Clingan SE; Mooney LJ; Curtis ME; Marsch LA; McLeman B; Hichborn E; Lester LS; Baldwin LM; Liu Y; Jacobs P; Saxon AJ
    Addict Sci Clin Pract; 2021 Apr; 16(1):24. PubMed ID: 33879260
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Harm Reduction Services in Ottawa: The Culture of Drug Use.
    Haines M; O'Byrne P
    Res Theory Nurs Pract; 2020 May; 34(2):188-202. PubMed ID: 32457123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.